http://www.themarketguardian.com/2009/06/hot-fda-trade-biodelivery-sciences-international/ Thu, 19 Jan 2012 00:29:43 +0000 hourly 1 http://wordpress.org/?v=3.2.1 http://www.themarketguardian.com/2009/06/hot-fda-trade-biodelivery-sciences-international/comment-page-1/#comment-1163 Monday Stock Play BDSI Mon, 15 Jun 2009 00:41:54 +0000 http://www.themarketguardian.com/?p=5139#comment-1163 [...] FREE Trend Analysis for BDSI Here Earlier this year, BDSI raised $6M in cash from partner Meda AB [STO:MEDAA] ($2.3B U.S. Dollar market cap) from a $3M expanded marketing agreement (which includes all countries except Taiwan and South Korea) and a $3M advance of the $30M milestone payment triggered by FDA approval. The remaining $27M cash milestone payment on FDA approval for Onsolis represents about 22% of the Company’s current market cap of $123M, in addition to double-digit royalties that will be received on product sales, an additional $30M possible in sales-related milestone payments, and a $5M milestone payment that is due upon EU approval/launch. Hat Tip Market Guardian [...] [...] FREE Trend Analysis for BDSI Here Earlier this year, BDSI raised $6M in cash from partner Meda AB [STO:MEDAA] ($2.3B U.S. Dollar market cap) from a $3M expanded marketing agreement (which includes all countries except Taiwan and South Korea) and a $3M advance of the $30M milestone payment triggered by FDA approval. The remaining $27M cash milestone payment on FDA approval for Onsolis represents about 22% of the Company’s current market cap of $123M, in addition to double-digit royalties that will be received on product sales, an additional $30M possible in sales-related milestone payments, and a $5M milestone payment that is due upon EU approval/launch. Hat Tip Market Guardian [...]

]]>